Sanofi

Better Than Lipitor! Higher Sales?

Better Than Lipitor! Higher Sales?

Motley Fool

BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013

BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013

Seeking Alpha

J&J Declines to Comment on U.S. Approval of Sanofi Deal

J&J Declines to Comment on U.S. Approval of Sanofi Deal

Bloomberg

3 Drug Disappointments From 2012

3 Drug Disappointments From 2012

Motley Fool

Sanofi Pays $109M To Settle Kickback Charges

Sanofi Pays $109M To Settle Kickback Charges

Pharmalot

Glaxo's Genital Herpes Vaccine Flops But Genocea's Next-Generation Approach Makes It A Buy

Glaxo's Genital Herpes Vaccine Flops But Genocea's Next-Generation Approach Makes It A Buy

Seeking Alpha

The Next Wave of Diabetes Dominance

The Next Wave of Diabetes Dominance

Motley Fool

Sanofi's last on the list to buy Bayer's glucose devices

Sanofi's last on the list to buy Bayer's glucose devices

Mass Device

Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint

Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint

Yahoo/PR Newswire

7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013

7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013

Seeking Alpha